$407.05-9.32 (-2.24%)
Corpay, Inc.
Corpay, Inc. in the Technology sector is trading at $407.05 with a market capitalization of $27.4B. Wall Street consensus targets $461.00 (15 analysts), implying a +13.3% move over the next 12 months. The stock is currently near its 52-week high of $427.46, remaining 20.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.26B↑ | $1.25B↑ | $1.17B↑ | $1.10B |
| Gross Profit | — | $988.92M | $988.17M↑ | $923.72M↑ | $863.51M |
| Operating Income | — | $514.74M↓ | $522.21M↓ | $523.12M↑ | $479.39M |
| Net Income | — | $350.07M↑ | $264.48M↓ | $277.94M↓ | $284.17M |
Corpay, Inc. operates as a payments company that helps businesses and consumers to manage and pay their expenses. It operates through Corporate Payments, Vehicle Payments, Lodging Payments, and Other segments. The company offers vehicle payment solut...

Corpay (CPAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Corpay's sustained organic growth, stronger 2026 outlook and aggressive buybacks are supporting continued earnings momentum.

On August 5, Corpay (NYSE:CPAY) delivered two headlines in one breath. The corporate payments company reported second-quarter results that beat its own targets, and it agreed to sell a UK fleet software business it no longer sees as core. Revenue climbed 21% to $1,338.8 million and adjusted earnings per share jumped 36% to $7.00, yet […]
The Bank of Canada may have little choice but to dial back its recent hawkish stance at Wednesday's
Savills leased an entire floor at Rudin's 560 Lexington Ave., adding to a tower that has signed over 110,000 SF of deals this year.
Academic risk and quality models computed from CPAY's own filings and price history, not from analyst opinion.
Mixed: 4 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 30.6% reading.
Fama-French 5-factor market beta. The five factors explain 22% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.